Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain practical insight into how integrating MOUD prescribing into pharmacy practice can improve treatment access while maintaining safe, evidence-based care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Korey Kreider, PharmD
Pharmacist Owner
Medicine Man

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent federal policy changes authorizing pharmacists to independently prescribe buprenorphine for opioid use disorder.
2. Identify clinical, regulatory, and workflow considerations associated with integrating MOUD prescribing into pharmacy practice

Rachel Maynard and Korey Kreider have no relevant financial relationships with ineligible companies to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-150-H01-P
Initial release date: 5/11/2026
Expiration date: 5/11/2027
Additional CPE details can be found here.

Updated cholesterol guidelines introduce important changes in cardiovascular risk assessment and lipid management that directly impact pharmacist practice. This course reviews key updates from the new ACC/AHA dyslipidemia guideline, including risk assessment tools, LDL-C targets, and evolving roles for statin and nonstatin therapies. You will be better prepared to identify practice-relevant recommendations and support evidence-based lipid management in patient care.

HOST

Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Janelle Ruisinger, PharmD, FAPhA
Associate Dean for Academic Affairs and Clinical Professor
The University of Kansas School of Pharmacy

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe key pharmacist-relevant updates in the new ACC/AHA Guideline for the Management of Dyslipidemia.
2. Differentiate risk assessment and lipid-lowering treatment considerations that may influence pharmacist recommendations under the updated guideline.

Rachel Maynard and Janelle Ruisinger have no relevant financial relationships to disclose.

0.75 CEU/0.75 Hr
UAN: 0107-0000-26-156-H01-P
Initial release date: 5/4/2026
Expiration date: 5/4/2027
Additional CPE details can be found here.

Join host Dr. Britney Woods, PharmD, Sr. Manager of Community Pharmacy at McKesson Health Mart, for a compelling conversation about the power of automation in independent pharmacies. This episode features special guests Faisal Adam, Pharmacist at Mark’s Pharmacy, and Alisha Nanji, Pharmacy Manager with McKesson Canada, who share their firsthand experiences on how thoughtfully implemented automation can help transform daily operations, ease the workload for pharmacy teams, and elevate patient care. Listen in as they explore practical strategies for unlocking real capacity and efficiency in the pharmacy setting and discover how embracing technology can help make a meaningful difference for both your staff and patients.

Host
Britney Woods, PharmD
Sr. Manager, Community Pharmacy
McKesson / Health Mart

Guests
Faisal Adam, PharmD
Pharmacist
Mark's Pharmacy

Alisha Nanji, HBSc, BSc Phm, RPh, (ON/NB)
Pharmacy Manager
McKesson Canada

Resources
You can learn more about McKesson Pharmacy Automation Services here: https://www.mckesson.com/automation/

References
Health Mart Pharmacies can access Health Mart University (HMU) for:

• Helpful CE courses and more on inventory management and workflow
• Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes

The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Seasonal allergies affect millions of patients each year and are a common reason individuals seek guidance from pharmacists for symptom relief and product selection. This course reviews the pathophysiology, common symptoms, and current management strategies for seasonal allergies, with a focus on over-the-counter treatment options and patient counseling considerations. You will strengthen your ability to recommend evidence-based therapies, differentiate treatment options, and support patients in managing seasonal allergy symptoms effectively.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Tyler Kiles, PharmD, MPH, BC-ADM
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the pathophysiology, common symptoms, and underlying causes of seasonal allergic rhinitis.
2. Compare pharmacologic and nonpharmacologic treatment options for seasonal allergies, including considerations for safe and effective use in patient care.

Rachel Maynard and Tyler Kiles have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-155-H01-P
Initial release date: 4/27/2026
Expiration date: 4/27/2027
Additional CPE details can be found here.

Federal guidelines now recognize self‑collected HPV testing as an option for cervical cancer screening for average‑risk individuals, offering a more accessible and patient‑preferred alternative to clinician‑collected samples. This course explains current guideline updates supporting self‑collection, highlights screening intervals and follow‑up recommendations, and explores how pharmacists can support patients in choosing appropriate screening options and navigating coverage and reimbursement. You will learn practical strategies to educate patients, help them understand test options and results, and integrate HPV self‑screening into preventive health services in your practice.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Sarah Westberg, PharmD, FCCP, BCPS
Professor & Associate Dean for Professional Affairs
University of Minnesota College of Pharmacy

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent guideline updates supporting self‑collected HPV testing as part of cervical cancer screening.
2. Identify pharmacist‑led strategies to counsel patients on self‑screening options, appropriate follow‑up steps, and considerations related to insurance coverage and reimbursement.

Rachel Maynard and Sarah Westberg have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-075-H01-P
Initial release date: 4/20/2026
Expiration date: 4/20/2027
Additional CPE details can be found here.

Treatment for atopic dermatitis has changed dramatically, with new therapies offering more targeted relief across the severity spectrum. This course highlights recent drug approvals, updated guideline recommendations, and the clinical implications of managing atopic dermatitis as a chronic inflammatory condition. You will learn how pharmacists can guide therapy decisions, enhance adherence, and improve patient outcomes in personalized atopic dermatitis care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Melanie Plotke, PharmD
Manager, Clinical Research
American Academy of Dermatology

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the updated treatment landscape for atopic dermatitis, including new topical and systemic options.
2. Identify opportunities for pharmacists to collaborate and support atopic dermatitis management through therapy recommendations, patient education, and adherence strategies.

Rachel Maynard and Melanie Plotke have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-074-H01-P
Initial release date: 4/13/2026
Expiration date: 4/13/2027
Additional CPE details can be found here.

Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmacist-driven interventions.

Recent ACC/AHA Cholesterol Guidelines further emphasize comprehensive cardiovascular risk assessment and evidence-based management of dyslipidemia alongside other major risk factors such as hypertension. These updates complement the hypertension topics discussed in this episode by reinforcing the importance of coordinated, risk-based approaches to reducing cardiovascular disease.

This resource provides a concise, guideline-based overview of hypertension management, summarizing the 2025 ACC/AHA recommendations for blood pressure classification, treatment goals, and stepwise pharmacotherapy. It highlights first- and second-line antihypertensive options, emphasizes individualized, risk-based treatment decisions, and outlines practical considerations for therapy initiation, intensification, and monitoring to optimize cardiovascular outcomes.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, CDCES, AACC
Clinical Pharmacist Practitioner
LTC Charles S. Kettles VA Medical Center

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify recent guideline and practice updates that may influence the diagnosis, treatment, and monitoring of hypertension.
2. Discuss current and emerging tools and strategies that support safe, effective, and individualized hypertension management.

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Tomasz Jurga has disclosed that a grant from Merck supported Pharmacy Times Continuing Education activities, including speaking honoraria. All relevant financial relationships have been mitigated.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-073-H01-P
Initial release date: 4/6/2026
Expiration date: 4/6/2027
Additional CPE details can be found here.

Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford to overlook. This course discusses the pathophysiology of the syndrome, common triggers, and emerging case trends—while highlighting how pharmacists can play a critical role in helping patients navigate safe OTC and prescription therapies by screening for allergenic excipients. You will gain practical knowledge to support patient education, ensure safe medication use, and guide appropriate referrals.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Geoff Wall, PharmD, BCPS
Professor of Pharmacy Practice
Drake University

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the pathophysiology, triggers, and clinical presentation of alpha‑gal syndrome.
2. Identify pharmacist‑led strategies for patient counseling, medication review, and referral when AGS is suspected or confirmed.

Rachel Maynard and Geoff Wall have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-058-H01-P
Initial release date: 3/30/2026
Expiration date: 3/30/2027
Additional CPE details can be found here.